Overview of the Jak inhibitors as targeted biologic therapies in... | Download Scientific Diagram
Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot - Gastroenterology
Frontiers | Emerging Topical and Systemic JAK Inhibitors in Dermatology
A pan-JAK inhibitor blocks IL-17A-induced TEER enhancement. (A) A... | Download Scientific Diagram
Cancers | Free Full-Text | Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors—A Strategy for Hematological Malignancies?
A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future? - Liu - 2021 - Arthritis & Rheumatology - Wiley Online Library
JAK阻害 | JAK Inhibition
JAK-STAT pathway and JAK inhibitors: a primer for dermatologists
JAK inhibitors and COVID-19 | Journal for ImmunoTherapy of Cancer
A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink
A Dual Inhibition, a Better Solution: Development of a JAK1/TYK2 inhibitor | Journal of Medicinal Chemistry
Frontiers | Hi-JAKi-ng Synovial Fibroblasts in Inflammatory Arthritis With JAK Inhibitors
A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink
JAK Inhibitors: Prospects in Connective Tissue Diseases | SpringerLink
Selective JAK inhibitors | Future Medicinal Chemistry
The emerging safety profile of JAK inhibitors in rheumatic disease | Nature Reviews Rheumatology
Selective Janus kinase inhibitors come of age | Nature Reviews Rheumatology
Safety of Janus kinase (JAK) inhibitors in the short‐term treatment of atopic dermatitis - Wood - 2022 - International Journal of Dermatology - Wiley Online Library
Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases | SpringerLink
Current and future status of JAK inhibitors - The Lancet
The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions - Journal of Allergy and Clinical Immunology
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology
Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases | Journal of Medicinal Chemistry
Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases - ScienceDirect
JAK inhibitors for the treatment of autoimmune and inflammatory diseases - ScienceDirect
